Keeping up with corporate filings shouldn't be a full-time job.

Lack of time and motivation to wade through dense documents means missing out on portfolio-boosting opportunities.

Stay informed, invest smarter: AI-powered corporate filing summaries.

Setup Free Alerts → Browse Latest Filings
Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

1251
1
New Fortress Energy Inc. New Fortress Energy Reports Mixed Q3 2024 Results with Increased Revenues and Assets, but Decreased Profitability

Via official filing (AI summary) | 11 days ago | 0 comments

1252
1
Groupon, Inc. Groupon Reports Mixed Q3 2024 Results, Net Income Turnaround Amid Restructuring Efforts

Via official filing (AI summary) | 11 days ago | 0 comments

1253
1
LIXTE BIOTECHNOLOGY HOLDINGS, INC. Lixte Biotechnology Reports No Revenue, Net Loss in Q3 2024, Cites Need for Additional Capital

Via official filing (AI summary) | 11 days ago | 0 comments

1254
1
Lument Finance Trust, Inc. Lument Finance Trust Reports Mixed Q3 Results, Net Income Up 22% for Nine Months

Via official filing (AI summary) | 11 days ago | 0 comments

1255
1
Legacy Housing Corp Legacy Housing Corporation Reports Decline in Net Revenue and Product Sales for Q3 and Nine Months Ended September 30, 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1256
1
NEWPARK RESOURCES INC Newpark Resources Reports Mixed Q3 Results Following Fluids Systems Sale

Via official filing (AI summary) | 11 days ago | 0 comments

1257
1
Everi Holdings Inc. Everi Holdings Reports 18% Revenue Decline, Net Loss in Q3 2024 Amid Acquisition Plans

Via official filing (AI summary) | 11 days ago | 0 comments

1258
1
Montauk Renewables, Inc. Montauk Renewables Reports 18.4% Revenue Growth, 35.3% Operating Income Increase in Q3 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1259
1
Terns Pharmaceuticals, Inc. Terns Pharmaceuticals Reports Significant Financial Growth and Milestones in Latest 10-Q Filing

Via official filing (AI summary) | 11 days ago | 0 comments

1260
1
Healthcare Trust, Inc. National Healthcare Properties Reports Net Loss and Increased Expenses for Q3 and Nine Months Ended September 30, 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1261
1
Capital Bancorp Inc Capital Bancorp Reports 15% Asset Growth, Net Income Decline in Q3 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1262
1
NewtekOne, Inc. NewtekOne Reports 17.1% Growth in Total Assets, Net Interest Income Increases 59.3%

Via official filing (AI summary) | 11 days ago | 0 comments

1263
1
MILLER INDUSTRIES INC /TN/ Miller Industries Reports 14.5% Revenue Growth, Net Income Decline in Latest Quarter

Via official filing (AI summary) | 11 days ago | 0 comments

1264
1
Hoth Therapeutics, Inc. Hoth Therapeutics Reports Third Quarter and Nine Months Financial Results, Reduces Losses Amid Focus on Development Pipeline

Via official filing (AI summary) | 11 days ago | 0 comments

1265
1
Embrace Change Acquisition Corp. Embrace Change Acquisition Corp. Reports Financial Changes, Withdraws Funds for Redemptions

Via official filing (AI summary) | 11 days ago | 0 comments

1266
1
TALOS ENERGY INC. Talos Energy Reports Revenue Growth, Net Income Recovery, and Strategic Acquisitions in Q3 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1267
1
vTv Therapeutics Inc. vTv Therapeutics Reports Improved Liquidity and Reduced Net Losses in Q3 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1268
1
Silo Pharma, Inc. Silo Pharma Reports 9-Month Financial Results, Highlighting Increased Research Expenses and Improved Liquidity

Via official filing (AI summary) | 11 days ago | 0 comments

1269
1
CHICAGO RIVET & MACHINE CO Chicago Rivet & Machine Co. Reports 12.3% Revenue Decline, Net Loss in Q3 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1270
1
Cherry Hill Mortgage Investment Corp Cherry Hill Mortgage Investment Corporation Reports Mixed Q3 2024 Results, Net Loss, and Strategic Developments

Via official filing (AI summary) | 11 days ago | 0 comments

1271
1
TRANSACT TECHNOLOGIES INC TransAct Technologies Reports Significant Declines in Financial Performance for Q3 and Nine Months Ended September 30, 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1272
1
Aerovate Therapeutics, Inc. Aerovate Therapeutics Reports Net Loss of $16.2M, Announces Merger Agreement with Jade Biosciences

Via official filing (AI summary) | 11 days ago | 0 comments

1273
1
SYNLOGIC, INC. Synlogic Reports Significant Financial Decline, Net Loss, and Restructuring Efforts in Latest 10-Q Filing

Via official filing (AI summary) | 11 days ago | 0 comments

1274
1
EBR Systems, Inc. EBR Systems Reports Net Loss of $10.1M in Q3 2024, Sees Increased Expenses and Decreased Cash Reserves

Via official filing (AI summary) | 11 days ago | 0 comments

1275
1
BAXTER INTERNATIONAL INC Baxter International Reports Mixed Q3 2024 Results Amid Strategic Developments and Operational Disruptions

Via official filing (AI summary) | 11 days ago | 0 comments